Home › Companies › FULGENT GENETICS INC. › 2024-2025

FULGENT GENETICS INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and FULGENT GENETICS INC.’s Form 8-K, filed 2025-05-15 (Item 5.07 on EDGAR). Page generated 04 October 2026.

  • 6Ballot items
  • 244Asset managers
  • 1,519Fund votes
  • 2025-05-15Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore FULGENT GENETICS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by FULGENT GENETICS INC.

These tallies are FULGENT GENETICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-05-15 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

FULGENT GENETICS INC. — official shareholder meeting results, meeting held 2025-05-15
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Ming Hsieh 19,305,664---- 839,0205,175,244 Majority: yes
Elect Director: Michael Nohaile, Ph.D. 16,003,908---- 4,140,7765,175,244 Majority: yes
Elect Director: Regina Groves 14,263,988---- 5,880,6965,175,244 Majority: yes
Elect Director: Linda Marsh 13,816,654---- 6,328,0305,175,244 Majority: yes
Proposal 2 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. 25,177,291114,79327,844 ---- Majority: yes
Proposal 3 Approval, on a non-binding advisory basis, the compensation of the Company's named executive officers. 16,269,4633,814,78860,433 --5,175,244 Majority: yes

Source: FULGENT GENETICS INC., Form 8-K, filed with the SEC on 2025-05-15 — read the filing on EDGAR.

How asset managers voted at the FULGENT GENETICS INC. 2024-2025 meeting

Each item below shows how the 244 asset managers that disclosed a FULGENT GENETICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. To approve, on an advisory basis, the compensation awarded to the Company's named executive officers (Say-on-Pay).

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

81% Majority: yes · of votes cast

FOR 81%AGAINST 19%
FOR: 16,269,463AGAINST: 3,814,788

FULGENT GENETICS INC.’s own tally for this item (“Proposal 3 Approval, on a non-binding advisory basis, the compensation of the Company's named executive officers.”): 16,269,463 for, 3,814,788 against, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 30,621,000 outstanding shares: 53.1% for, 12% against (66% of the company cast a for/against vote).

The 242 asset managers below cast 69% of the shares they voted on this item FOR (7,544,277 for, 3,428,542 against).

FOR 69%AGAINST 31%
FOR: 7,544,277 (68.6%)AGAINST: 3,428,542 (31.2%)ABSTAIN: 22,670 (0.2%)NOT VOTED: 507 (0.0%)
Largest asset managers voting on “To approve, on an advisory basis, the compensation awarded to the Company's named executive officers (Say-on-P” at FULGENT GENETICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock2,684,92518,540 00For
Vanguard1,400,852757 00For
Dimensional0683,219 00Against
Columbia Threadneedle0576,389 00Against
Park West Asset Management LLC447,9420 00For
GEODE CAPITAL MANAGEMENT, LLC417,5590 00For
Charles Schwab0400,272 00Against
Fidelity373,9220 00For
State Street332,3487,924 00For
Invenomic Capital Management LP254,1630 00For
Northern Trust202,9374,717 00For
NORTHERN LIGHTS FUND TRUST II207,4540 00For
JPMorgan193,7600 00For
Connor, Clark & Lunn Investment Management Ltd.0150,157 00Against
Citadel147,7090 00For
TCW GROUP INC123,4000 00For
MELLON INVESTMENTS Corp109,4720 00For
PRINCIPAL GLOBAL INVESTORS0103,238 00Against
PARAMETRIC PORTFOLIO ASSOCIATES LLC096,011 00Against
American Century095,933 00Against
Two Sigma094,805 00Against
Federated Hermes92,9580 00For
AMERIPRISE FINANCIAL INC082,251 00Against
Point72065,463 00Against
BNY Mellon64,7250 00For

Showing the 25 largest of 242 asset managers. See all 242 in the interactive database.

2. Election of Directors: Linda Marsh

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

69% Majority: yes · of votes cast

FOR 69%WITHHELD 31%
FOR: 13,816,654WITHHELD: 6,328,030

FULGENT GENETICS INC.’s own tally for this item (“Elect Director: Linda Marsh”): 13,816,654 for, 6,328,030 withheld, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 30,621,000 outstanding shares: 45.1% for, 21% withheld (66% of the company cast a for/withheld vote).

The 65 asset managers below cast 100% of the shares they voted on this item FOR (2,907,494 for, 0 against).

FOR 49.3%ABSTAIN 50.7%
FOR: 2,907,494 (49.3%)ABSTAIN: 2,986,660 (50.7%)
Largest asset managers voting on “Election of Directors: Linda Marsh” at FULGENT GENETICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock00 1,726,2280Abstain
Vanguard1,360,5900 70For
Columbia Threadneedle00 576,3890Abstain
Dimensional557,4950 00For
Fidelity364,6190 8,2450For
NORTHERN LIGHTS FUND TRUST II207,4540 00For
Charles Schwab185,5780 00For
JPMorgan00 92,0250Abstain
TIAA55,7940 00For
DWS00 53,8990Abstain
Equitable00 52,8430Abstain
American Century00 47,8820Abstain
Global X47,4950 00For
Federated Hermes00 46,4790Abstain
Jackson National7,4690 33,9370Abstain
State Street36,1520 7050For
QUANTITATIVE MASTER SERIES LLC00 34,7310Abstain
EXCHANGE TRADED CONCEPTS TRUST00 33,2800Abstain
Bridge Builder Trust00 32,5490Abstain
Lincoln Financial18,7230 10,4600For
ALPS ETF Trust00 23,1480Abstain
EA Series Trust00 22,6700Abstain
Goldman Sachs00 22,1740Abstain
BNY Mellon00 22,0680Abstain
Principal00 20,6880Abstain

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

3. Election of Directors: Michael Nohaile, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

79% Majority: yes · of votes cast

FOR 79%WITHHELD 21%
FOR: 16,003,908WITHHELD: 4,140,776

FULGENT GENETICS INC.’s own tally for this item (“Elect Director: Michael Nohaile, Ph.D.”): 16,003,908 for, 4,140,776 withheld, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 30,621,000 outstanding shares: 52.3% for, 14% withheld (66% of the company cast a for/withheld vote).

The 65 asset managers below cast 100% of the shares they voted on this item FOR (4,210,154 for, 0 against).

FOR 71%ABSTAIN 29%
FOR: 4,210,154 (71.4%)ABSTAIN: 1,684,000 (28.6%)
Largest asset managers voting on “Election of Directors: Michael Nohaile, Ph.D.” at FULGENT GENETICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock1,704,4770 21,7510For
Vanguard1,360,1450 4520For
Columbia Threadneedle00 576,3890Abstain
Dimensional557,4950 00For
Fidelity372,8640 00For
NORTHERN LIGHTS FUND TRUST II00 207,4540Abstain
Charles Schwab00 185,5780Abstain
JPMorgan00 92,0250Abstain
TIAA00 55,7940Abstain
DWS00 53,8990Abstain
Equitable32,6730 20,1700For
American Century00 47,8820Abstain
Global X00 47,4950Abstain
Federated Hermes00 46,4790Abstain
Jackson National7,4690 33,9370Abstain
State Street36,1520 7050For
QUANTITATIVE MASTER SERIES LLC34,7310 00For
EXCHANGE TRADED CONCEPTS TRUST00 33,2800Abstain
Bridge Builder Trust9,3700 23,1790Abstain
Lincoln Financial18,7230 10,4600For
ALPS ETF Trust00 23,1480Abstain
EA Series Trust00 22,6700Abstain
Goldman Sachs00 22,1740Abstain
BNY Mellon00 22,0680Abstain
Principal00 20,6880Abstain

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

4. Election of Directors: Ming Hsieh

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 19,305,664WITHHELD: 839,020

FULGENT GENETICS INC.’s own tally for this item (“Elect Director: Ming Hsieh”): 19,305,664 for, 839,020 withheld, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 30,621,000 outstanding shares: 63% for, 3% withheld (66% of the company cast a for/withheld vote).

The 65 asset managers below cast 100% of the shares they voted on this item FOR (5,870,319 for, 0 against).

FOR 99.5%
FOR: 5,870,319 (99.6%)ABSTAIN: 23,835 (0.4%)
Largest asset managers voting on “Election of Directors: Ming Hsieh” at FULGENT GENETICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock1,726,2280 00For
Vanguard1,360,5960 10For
Columbia Threadneedle576,3890 00For
Dimensional557,4950 00For
Fidelity372,8640 00For
NORTHERN LIGHTS FUND TRUST II207,4540 00For
Charles Schwab185,5780 00For
JPMorgan92,0250 00For
TIAA55,7940 00For
DWS53,8990 00For
Equitable32,6730 20,1700For
American Century47,8820 00For
Global X47,4950 00For
Federated Hermes46,4790 00For
Jackson National41,4060 00For
State Street36,8570 00For
QUANTITATIVE MASTER SERIES LLC34,7310 00For
EXCHANGE TRADED CONCEPTS TRUST33,2800 00For
Bridge Builder Trust32,5490 00For
Lincoln Financial29,1830 00For
ALPS ETF Trust23,1480 00For
EA Series Trust22,6700 00For
Goldman Sachs22,1740 00For
BNY Mellon22,0680 00For
Principal20,6880 00For

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

5. Election of Directors: Regina Groves

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

71% Majority: yes · of votes cast

FOR 71%WITHHELD 29%
FOR: 14,263,988WITHHELD: 5,880,696

FULGENT GENETICS INC.’s own tally for this item (“Elect Director: Regina Groves”): 14,263,988 for, 5,880,696 withheld, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 30,621,000 outstanding shares: 46.6% for, 19% withheld (66% of the company cast a for/withheld vote).

The 65 asset managers below cast 100% of the shares they voted on this item FOR (2,907,494 for, 0 against).

FOR 49.3%ABSTAIN 50.7%
FOR: 2,907,494 (49.3%)ABSTAIN: 2,986,660 (50.7%)
Largest asset managers voting on “Election of Directors: Regina Groves” at FULGENT GENETICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock00 1,726,2280Abstain
Vanguard1,360,5900 70For
Columbia Threadneedle00 576,3890Abstain
Dimensional557,4950 00For
Fidelity364,6190 8,2450For
NORTHERN LIGHTS FUND TRUST II207,4540 00For
Charles Schwab185,5780 00For
JPMorgan00 92,0250Abstain
TIAA55,7940 00For
DWS00 53,8990Abstain
Equitable00 52,8430Abstain
American Century00 47,8820Abstain
Global X47,4950 00For
Federated Hermes00 46,4790Abstain
Jackson National7,4690 33,9370Abstain
State Street36,1520 7050For
QUANTITATIVE MASTER SERIES LLC00 34,7310Abstain
EXCHANGE TRADED CONCEPTS TRUST00 33,2800Abstain
Bridge Builder Trust00 32,5490Abstain
Lincoln Financial18,7230 10,4600For
ALPS ETF Trust00 23,1480Abstain
EA Series Trust00 22,6700Abstain
Goldman Sachs00 22,1740Abstain
BNY Mellon00 22,0680Abstain
Principal00 20,6880Abstain

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

6. TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 25,177,291AGAINST: 114,793

FULGENT GENETICS INC.’s own tally for this item (“Proposal 2 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”): 25,177,291 for, 114,793 against, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 30,621,000 outstanding shares: 82% for, 0.4% against (83% of the company cast a for/against vote).

The 65 asset managers below cast 99.4% of the shares they voted on this item FOR (5,859,441 for, 34,713 against).

FOR 99.4%
FOR: 5,859,441 (99.4%)AGAINST: 34,713 (0.6%)ABSTAIN: 0 (0.0%)
Largest asset managers voting on “TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING F” at FULGENT GENETICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock1,726,2280 00For
Vanguard1,360,5970 00For
Columbia Threadneedle576,3890 00For
Dimensional557,4950 00For
Fidelity372,8640 00For
NORTHERN LIGHTS FUND TRUST II207,4540 00For
Charles Schwab185,5780 00For
JPMorgan92,0250 00For
TIAA55,7940 00For
DWS53,8990 00For
Equitable52,8430 00For
American Century47,8820 00For
Global X47,4950 00For
Federated Hermes46,4790 00For
Jackson National41,4060 00For
State Street36,8561 00For
QUANTITATIVE MASTER SERIES LLC34,7310 00For
EXCHANGE TRADED CONCEPTS TRUST33,2800 00For
Bridge Builder Trust32,5490 00For
Lincoln Financial29,1830 00For
ALPS ETF Trust23,1480 00For
EA Series Trust022,670 00Against
Goldman Sachs22,1740 00For
BNY Mellon22,0680 00For
Principal20,6880 00For

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

Largest FULGENT GENETICS INC. shareholders voting in 2024-2025

Ranked by the number of FULGENT GENETICS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 30,621,000 shares outstanding at the time of that meeting.

Top FULGENT GENETICS INC. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1BlackRock 8.83%
2Vanguard 4.58%
3Dimensional 2.23%
4Columbia Threadneedle 1.88%
5Park West Asset Management LLC 1.46%
6GEODE CAPITAL MANAGEMENT, LLC 1.36%
7Charles Schwab 1.31%
8Fidelity 1.22%
9State Street 1.11%
10Invenomic Capital Management LP 0.83%

Reported FULGENT GENETICS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

FULGENT GENETICS INC. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
Ming Hsieh 28.98% 13D
Barclays PLC 7.64% 13G
BlackRock 7.33% 13F
Millennium Management 6.43% 13F
Barclays Bank PLC 5.41% DEF14A
Ramya Rao 5.41% 13G
Vanguard Group 3.81% 13F
Dimensional Fund Advisors 3.36% 13F
Integrated Core Strategies (US) LLC 3.00% 13G
Hanlin Gao, M.D., Ph.D., D.A.B.M.G., F.A.C.M.G. 2.88% DEF14A

Percentages above are of 30,621,000 shares outstanding, as reported by FULGENT GENETICS INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from FULGENT GENETICS INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At FULGENT GENETICS INC.'s shareholder meeting held 2025-05-15, in the 2024-2025 proxy season, 244 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 1,519 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation awarded to the Company's named executive… — FOR was 81% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: FULGENT GENETICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-05-15.

FULGENT GENETICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.